BUDAPEST, Hungary, March 28, 2018 /PRNewswire/ --
The consolidated EBITDA for the Darholding companies rose sharplyby 57%, compared with previous year, partly as a result of our continuous reorganization efforts, while the consolidated revenue increased by 5% to EUR 9.6 million. As a recognition of our innovative stance, three EU grants
Darholding is a Budapest based upstream innovation incubating organization with interests in scientific research in pharmaceuticals, agrochemicals, fine chemicals, flavors and fragrances, laboratory instrumentation and chemistry development in Space. It operates globally through a network of companies who are all pioneers in their chosen field.
Contact: Gergely Darvas Investment Director Darholding Ltd email@example.com +36-1-880-8500
SOURCE Darholding Ltd.
Subscribe to our Free Newsletters!
Necrotizing fasciitis is a rare life threatening bacterial infection of the tissue below the skin ...
Menstruation or period is the discharge of blood and mucus called menses from the uterus via the ...
Chronic dieting is associated with eating disorders that mainly include unhealthy eating practices ...View All